USask scientists receive $1M to improve mpox preparedness


Scientists from the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) have been granted $1M in funding from the Canadian Institutes of Health Research (CIHR) to study mpox. Specifically, the team of scientists will analyze mpox transmission and host responses to mpox infection. “Strengthening capacity and expertise is critical to respond to emerging and re-emerging infectious diseases–like mpox–and further defines VIDO role as Canada’s Centre for Pandemic Research,” said VIDO Director Dr Volker Gerdts. “The support from CIHR will help prevent future outbreaks of mpox and other related viruses in Canada and globally.”